Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus

Association Between Serum Lipoprotein(a) and Diabetic Retinopathy in Han Chinese Patients With Type 2 Diabetes

(2017) Wen-Jun Tu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes

(2017) Thijs T. W. van Herpt et al.   Diabetology & Metabolic Syndrome

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials

(2017) Sophia Zoungas et al.   Lancet Diabetes & Endocrinology

Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases

(2016) Florian Kronenberg   CARDIOVASCULAR DRUGS AND THERAPY

Lipoprotein(a) predicts the development of diabetic retinopathy in people with type 2 diabetes mellitus

(2016) Jae-Seung Yun et al.   Journal of Clinical Lipidology

Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus

(2016) Hidenori Senba et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Structure, function, and genetics of lipoprotein (a)

(2016) Konrad Schmidt et al.   JOURNAL OF LIPID RESEARCH

Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

(2016) Nicholas J Viney et al.   LANCET

Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk AssessmentSignificance

(2015) Weihua Guan et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus

(2015) J.-S. Yun et al.   DIABETIC MEDICINE

Lipoprotein (a) measurements for clinical application

(2015) Santica M. Marcovina et al.   JOURNAL OF LIPID RESEARCH

Lipoprotein (a): impact by ethnicity and environmental and medical conditions

(2015) Byambaa Enkhmaa et al.   JOURNAL OF LIPID RESEARCH

Diabetes mellitus and renal failure: Prevention and management

(2015) Mahmoud Rafieian-Kopaei et al.   Journal of Research in Medical Sciences

Statistical power and significance testing in large-scale genetic studies

(2014) Pak C. Sham et al.   NATURE REVIEWS GENETICS

Lipoprotein(a): resurrected by genetics

(2013) F. Kronenberg et al.   JOURNAL OF INTERNAL MEDICINE

Causes of vision loss worldwide, 1990–2010: a systematic analysis

(2013) Rupert R A Bourne et al.   Lancet Global Health

Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects

(2011) Salim S. Virani et al.   CIRCULATION

Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes

(2011) Qibin Qi et al.   EUROPEAN HEART JOURNAL

A Summary of the ADVANCE Trial

(2009) S. R. Heller et al.   DIABETES CARE

Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes

(2009) J. Lin et al.   DIABETOLOGIA

Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction

(2009) Pia R. Kamstrup   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality

(2009)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease

(2009) Robert Clarke et al.   NEW ENGLAND JOURNAL OF MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population

(2007) Pia R. Kamstrup et al.   CIRCULATION